Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Pietruszka

Optometrist Chicago, IL Doctor of Optometry

NPI 1679001101 CMS profile 2867245

555 S Dearborn St, Chicago, IL 60605

Open in the dashboard

General payments

$5,197

63 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Pietruszka of Chicago, IL is reported in the CMS Open Payments database as having received $5,197 across 63 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $187 2
2024 General $132 5
2023 General $3,571 13
2022 General $651 18
2021 General $158 6
2020 General $265 9
2019 General $231 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Pietruszka
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Matthew Pietruszka were reported at $187. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Matthew Pietruszka Optometrist median Middle half National median
2019 $231 $159 $67–$371 $163
2020 $265 $72 $29–$165 $114
2021 $158 $125 $46–$292 $132
2022 $651 $162 $66–$374 $149
2023 $3,571 $177 $72–$406 $160
2024 $132 $188 $77–$427 $164
2025 $187 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Johnson & Johnson Vision Care, Inc. $2,415 16 payments
  2. Alcon Vision LLC $1,327 7 payments
  3. CooperVision Inc. $773 20 payments
  4. Glaukos Corporation $226 2 payments
  5. Bausch & Lomb Americas Inc. $145 5 payments
  6. Sight Sciences, Inc. $73 2 payments
  7. Topcon Medical Systems, Inc. $53 1 payment
  8. ABB Con-Cise Optical Group LLC $51 3 payments
  9. RxSight Inc $46 2 payments
  10. Carl Zeiss Meditec AG $39 2 payments
  11. Other $50 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,236 55 payments
  2. Gift $2,056 4 payments
  3. Travel and Lodging $894 3 payments
  4. Entertainment $11 1 payment
Products named General payments · program years 2019–2025
  1. Acuvue $2,376 14 payments
  2. MyDay Contact Lens $460 11 payments
  3. Clariti Contact Lens $245 7 payments
  4. KXL system (not refurbished) $166 1 payment
  5. INFUSE $145 5 payments
  6. Paragon CRT $68 2 payments
  7. None Specified $56 3 payments
  8. Contact Lens $51 3 payments
  9. LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) $46 2 payments
  10. ILUX $44 1 payment
  11. Other $178 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record